
M. Franco G. Salvoza
Examiner (ID: 7294, Phone: (571)272-4468 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1672, 1648, 1671 |
| Total Applications | 794 |
| Issued Applications | 451 |
| Pending Applications | 120 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 540991
[patent_doc_number] => 07166426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-23
[patent_title] => 'HCV assay'
[patent_app_type] => utility
[patent_app_number] => 10/658782
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 17490
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/166/07166426.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658782
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658782 | HCV assay | Sep 7, 2003 | Issued |
Array
(
[id] => 7218208
[patent_doc_number] => 20050054846
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-10
[patent_title] => 'Method for generating influenza viruses and vaccines'
[patent_app_type] => utility
[patent_app_number] => 10/654737
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 8867
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20050054846.pdf
[firstpage_image] =>[orig_patent_app_number] => 10654737
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/654737 | Method for generating influenza viruses and vaccines | Sep 3, 2003 | Issued |
Array
(
[id] => 5747470
[patent_doc_number] => 20060110401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof'
[patent_app_type] => utility
[patent_app_number] => 10/522992
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13199
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110401.pdf
[firstpage_image] =>[orig_patent_app_number] => 10522992
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/522992 | Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof | Jul 31, 2003 | Abandoned |
Array
(
[id] => 7437624
[patent_doc_number] => 20040266987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'ATTENUATED FLAVIVRUS STRAINS CONTAINING A MUTATED M-ECTODOMAIN AND THEIR APPLICATIONS'
[patent_app_type] => new
[patent_app_number] => 10/608029
[patent_app_country] => US
[patent_app_date] => 2003-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9621
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266987.pdf
[firstpage_image] =>[orig_patent_app_number] => 10608029
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/608029 | Attenuated flavivirus strains containing a mutated M-ectodomain and their applications | Jun 29, 2003 | Issued |
Array
(
[id] => 6809010
[patent_doc_number] => 20030198949
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products'
[patent_app_type] => new
[patent_app_number] => 10/463808
[patent_app_country] => US
[patent_app_date] => 2003-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 48693
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0198/20030198949.pdf
[firstpage_image] =>[orig_patent_app_number] => 10463808
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/463808 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products | Jun 17, 2003 | Abandoned |
Array
(
[id] => 706851
[patent_doc_number] => 07060280
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-13
[patent_title] => 'Immunization against flavivirus'
[patent_app_type] => utility
[patent_app_number] => 10/459155
[patent_app_country] => US
[patent_app_date] => 2003-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5695
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060280.pdf
[firstpage_image] =>[orig_patent_app_number] => 10459155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/459155 | Immunization against flavivirus | Jun 10, 2003 | Issued |
Array
(
[id] => 6804642
[patent_doc_number] => 20030232036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Alphavirus RNA replicon systems'
[patent_app_type] => new
[patent_app_number] => 10/388327
[patent_app_country] => US
[patent_app_date] => 2003-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5906
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232036.pdf
[firstpage_image] =>[orig_patent_app_number] => 10388327
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/388327 | Alphavirus RNA replicon systems | Mar 12, 2003 | Issued |
Array
(
[id] => 6711789
[patent_doc_number] => 20030171538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus'
[patent_app_type] => new
[patent_app_number] => 10/359431
[patent_app_country] => US
[patent_app_date] => 2003-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 15444
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20030171538.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359431
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359431 | Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus | Feb 4, 2003 | Abandoned |
Array
(
[id] => 6796427
[patent_doc_number] => 20030175301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids'
[patent_app_type] => new
[patent_app_number] => 10/220267
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 6301
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175301.pdf
[firstpage_image] =>[orig_patent_app_number] => 10220267
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/220267 | Rotavirus pseudoviral particles and use thereof for vectorizing proteins of nucleic acids | Jan 29, 2003 | Abandoned |
Array
(
[id] => 7392573
[patent_doc_number] => 20040038202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Epizootic catarrhal enteritis prevention, treatment and diagnosis'
[patent_app_type] => new
[patent_app_number] => 10/354606
[patent_app_country] => US
[patent_app_date] => 2003-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 38555
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038202.pdf
[firstpage_image] =>[orig_patent_app_number] => 10354606
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/354606 | Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets | Jan 29, 2003 | Issued |
Array
(
[id] => 6769854
[patent_doc_number] => 20030215794
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Filovirus vectors and noninfectious Filovirus-based particles'
[patent_app_type] => new
[patent_app_number] => 10/353856
[patent_app_country] => US
[patent_app_date] => 2003-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 88
[patent_no_of_words] => 14390
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215794.pdf
[firstpage_image] =>[orig_patent_app_number] => 10353856
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/353856 | Filovirus vectors and noninfectious filovirus-based particles | Jan 28, 2003 | Issued |
Array
(
[id] => 6856243
[patent_doc_number] => 20030129744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Bvdv virus-like particles'
[patent_app_type] => new
[patent_app_number] => 10/312062
[patent_app_country] => US
[patent_app_date] => 2002-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5202
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10312062
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/312062 | Bvdv virus-like particles | Dec 19, 2002 | Abandoned |
Array
(
[id] => 6804930
[patent_doc_number] => 20030232324
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-18
[patent_title] => 'Chimeric alphavirus replicon particles'
[patent_app_type] => new
[patent_app_number] => 10/310734
[patent_app_country] => US
[patent_app_date] => 2002-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 33380
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0232/20030232324.pdf
[firstpage_image] =>[orig_patent_app_number] => 10310734
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/310734 | Chimeric alphavirus replicon particles | Dec 3, 2002 | Abandoned |
Array
(
[id] => 732217
[patent_doc_number] => 07037682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-05-02
[patent_title] => 'In vitro activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase'
[patent_app_type] => utility
[patent_app_number] => 10/231405
[patent_app_country] => US
[patent_app_date] => 2002-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 4667
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/037/07037682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10231405
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/231405 | In vitro activity assay for human hepatitis B virus (HBV) DNA polymerase, and its use for screening for inhibitors of HBV DNA polymerase | Aug 27, 2002 | Issued |
Array
(
[id] => 606148
[patent_doc_number] => 07153513
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-12-26
[patent_title] => 'West nile vaccine'
[patent_app_type] => utility
[patent_app_number] => 10/202716
[patent_app_country] => US
[patent_app_date] => 2002-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6096
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/153/07153513.pdf
[firstpage_image] =>[orig_patent_app_number] => 10202716
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/202716 | West nile vaccine | Jul 24, 2002 | Issued |
Array
(
[id] => 6735449
[patent_doc_number] => 20030013084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Organometallic probe'
[patent_app_type] => new
[patent_app_number] => 10/192853
[patent_app_country] => US
[patent_app_date] => 2002-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4683
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013084.pdf
[firstpage_image] =>[orig_patent_app_number] => 10192853
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/192853 | Organometallic probe | Jul 10, 2002 | Abandoned |
Array
(
[id] => 7385891
[patent_doc_number] => 20040180326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Avian leukosis viruses and polypeptide display'
[patent_app_type] => new
[patent_app_number] => 10/098935
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13124
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20040180326.pdf
[firstpage_image] =>[orig_patent_app_number] => 10098935
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/098935 | Avian leukosis viruses and polypeptide display | Mar 12, 2002 | Issued |
Array
(
[id] => 7082693
[patent_doc_number] => 20050048073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-03
[patent_title] => 'Methods of determining west nile virus epitopes and method of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/468950
[patent_app_country] => US
[patent_app_date] => 2002-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 40346
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20050048073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10468950
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/468950 | Methods of determining west nile virus epitopes and method of using the same | Feb 27, 2002 | Abandoned |
Array
(
[id] => 6618646
[patent_doc_number] => 20020086020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Method for improving the half-life of soluble viral receptors on mucosal membranes'
[patent_app_type] => new
[patent_app_number] => 10/043689
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12370
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086020.pdf
[firstpage_image] =>[orig_patent_app_number] => 10043689
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/043689 | Method for improving the half-life of soluble viral receptors on mucosal membranes | Jan 9, 2002 | Abandoned |
Array
(
[id] => 7261275
[patent_doc_number] => 20040241139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement'
[patent_app_type] => new
[patent_app_number] => 09/909238
[patent_app_country] => US
[patent_app_date] => 2001-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7413
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20040241139.pdf
[firstpage_image] =>[orig_patent_app_number] => 09909238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/909238 | Recombinant influenza viruses with bicistronic vRNAs coding for two genes in tandem arrangement | Jul 18, 2001 | Abandoned |